Antimicrobial Stewardship

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/30

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:07 PM on 4/10/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

31 Terms

1
New cards

Define bacterial resistance

Bacteria grow in the presence of clinically relevant concentrations of antibiotics

2
New cards

Which form of bacterial resistance is the greatest concern?

Acquired

3
New cards

What are urgent threats of emerging bacterial resistance?

Carbapenem-resistant Acinetobacter

Candida auris

Clostridioides difficile

Carbapenem-resistant Enterobacteriaceae

Drug-resistant Neisseria gonorrhoeae

4
New cards

Why do we need antibiotic stewardship?

Antibiotic overuse and misuse

5
New cards

What are problems with antimicrobial prescribing?

Low threshold for prescribing antimicrobials

Broad-spectrum empiric agents started, but lack of appropriate de-escalation

Use of suboptimal regimens

6
New cards

What are patient consequences of inappropriate therapy?

Inadequate treatment

Adverse effects

Allergic reactions

Superinfections

Selection of problematic pathogens

7
New cards

What are societal consequences of inappropriate therapy?

Antimicrobial resistance

"Collateral damage"

Increased healthcare costs

8
New cards

What are benefits of stewardship?

Improved patient outcomes

Decreased adverse events

Resource optimization

Reduce healthcare costs without sacrificing quality of care

9
New cards

What does the government require in regards to stewardship?

Requires hospitals to establish an antimicrobial stewardship program that meets required elements of performance

10
New cards

What are the CDC core elements of stewardship?

1. Leadership commitment

2. Accountability

3. Drug expertise

4. Action

5. Tracking

6. Reporting

7. Education

11
New cards

What are considered key ASP activities?

Prospective audit with intervention and feedback

Formulary restriction and pre-authorization

12
New cards

What actions can support optimal antibiotic use?

Document indication, dose, and duration

Facility specific guidelines for infectious disease states

Allergy assessment

Pre-authorization required for restricted/protected agents

Prospective audit and feedback (PAF)

13
New cards

What are pharmacy-driven interventions for stewardship?

Automatic changes from IV to PO antibiotics

Dose adjustments/optimization

Automatic alerts in situations where therapy might be unnecessarily duplicative

Time-sensitive automatic stop orders

Detection and prevention of antibiotic-related DDIs

14
New cards

When should a patient be switched from IV to PO antibiotics?

If stable, taking other PO drugs, and no concern for oral absorption

15
New cards

What are benefits of switching from IV to PO antibiotics?

Avoids potential complications of IV therapy and facilitates faster hospital discharge

16
New cards

Which antimicrobial drugs can be administered orally?

Fluoroquinolones

Macrolides

Azole antifungals

Metronidazole

Doxycycline, minocycline

Clindamycin

Linezolid

Rifampin

TMP-SMX

17
New cards

How can antimicrobial doses be optimized?

Renal dose adjustments

Pharmacodynamic optimization

18
New cards

What are the three types of pharmacodynamic optimizations?

Concentration-dependent

Time-dependent

Exposure-dependent

19
New cards

Which antibiotics are concentration-dependent?

Aminoglycosides

Daptomycin

20
New cards

Which antibiotics are time-dependent?

Beta-lactams

21
New cards

Which antibiotics are exposure dependent?

Vancomycin

Fluoroquinolones

22
New cards

Describe preauthorization in regards to stewardship

Certain antibiotics require approval by ID and/or antimicrobial stewardship team

23
New cards

Define prospective audit and feedback (PAF)

Antibiotic "time-outs" and reviews at 48-72 hours for patients on empiric antibiotics

Often broad-spectrum antibiotic

Culture data and patient-specific data typically available at 48-72 hours

24
New cards

What are advantages to using order sets and clinical pathways?

Decreases inappropriate use

Presents an opportunity for education

25
New cards

What are disadvantages to using order sets and clinical pathways?

Voluntary adherence

"Cookie cutter" method

Maintenance of materials

Awareness and access to resources

26
New cards

What process measures are used for tracking and monitoring?

Track antibiotic prescribing, use, and resistance

Documentation by providers

Adherence to guidelines

27
New cards

What outcome measures are used for tracking and monitoring?

Resistance patterns (antibiograms)

C. difficile rates

Clinical success difficult to measure

28
New cards

What are antibiotic use measures for tracking and monitoring?

Days of therapy (DOT)

Standardized antibiotic administration ratio (SAAR)

29
New cards

What is the preferred reporting measure of ASP impact?

Days of therapy (DOT)

30
New cards

What is the goal SAAR?

Goal is to be at 1

31
New cards

Describe DOT

Count each DAY each ANTIBIOTIC is given

Not impacted by dose adjustments

Useful in adults or pediatrics

Can measure overall, unit, or provider specific use